Universitätsklinikum Würzburg, Augenklinik und Poliklinik

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMD	Neovascular Age-related Macular Degeneration	Recruiting	Phase 3	2026-09-21		NCT06847542
A Study to Determine the Efficacy, Safety, and Durability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration	Neovascular Age-related Macular Degeneration (nAMD)	Active, not recruiting	Phase 4	2026-07-31		NCT06795048

Clinical trials